Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine.
about
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerCurcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryLow-dose curcumin stimulates proliferation, migration and phagocytic activity of olfactory ensheathing cellsThe spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritisA multi-targeted approach to suppress tumor-promoting inflammationDesign of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.Therapeutic applications of curcumin for patients with pancreatic cancer.N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferationAre curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.The Potential for Plant Derivatives against Acrylamide Neurotoxicity.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesDose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese miceThe role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells.Curcumin: updated molecular mechanisms and intervention targets in human lung cancer.A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.Beyond Yellow Curry: Assessing Commercial Curcumin Absorption TechnologiesEvolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in miceSystematic and comprehensive investigation of the toxicity of curcuminoid‑essential oil complex: A bioavailable turmeric formulation.Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer AgentsSafe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogsEvaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells.Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications.Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice.Bioavailability of polyphenol liposomes: a challenge aheadDevelopment and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin.Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes.Dietary regulation of P-gp function and expression.Curcumin implants, not curcumin diet, inhibit estrogen-induced mammary carcinogenesis in ACI rats.The targets of curcumin.Advances in nanotechnology-based delivery systems for curcumin.Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.Curcumin, a potential therapeutic candidate for retinal diseases.
P2860
Q24614491-EDC0B4CA-E4CA-472D-8384-BC211E4BCD28Q24630927-31DCAB8C-9C26-406B-8BF9-440ED8252AC6Q27332261-ECF025F3-D863-4891-91BA-CF4320ADF2D0Q28076995-5A02FDD1-DCBA-415F-BCDF-D4683BB8753CQ28393278-1B6DEE6B-0B25-48F4-8867-CC76BC84595EQ33500696-C59099F1-5298-497E-8943-760A8DB2D1E6Q33948351-22488AD9-9FE9-4D32-92F9-938C78A777EEQ34050685-189C4538-B1ED-4AB9-B053-E326D0F6EB45Q34060487-CC4CD406-194B-4109-974C-7048AF6012C9Q34245258-A5D0CC92-A4F4-4B61-AAEA-58A54E862741Q34328183-DFCEFCF2-F12E-4DCB-A4A4-3E9AAFE48233Q34362340-44BE3A20-188F-42B0-9B11-6AC3E71D0547Q34472327-74BDC805-F630-4BFE-A157-36B15F4B6362Q34594807-A081B278-243F-42D0-9F77-1D41034A01A3Q34629387-2B63006E-FCDE-4440-BFC2-0CB9E49437D7Q34660475-A7953FE0-8FFA-4CE9-ADA3-3A195175BD3DQ34675414-24538562-683B-4B75-8033-409291D84279Q35405562-D1AF5B54-4F15-42C4-B20F-4F82D2C78782Q35765642-8552B539-F83B-45D1-A6EA-9D2BDF2AC6AAQ35866113-A261F658-7EAF-48A0-BB5C-A42C14D12DCDQ35939307-F8F92C29-6688-4324-B76A-1C15E4013A07Q35955023-16E4748D-F8D8-40DA-BFB6-5D5BAF8AC6CEQ36010332-2F329D79-5DCD-429A-A168-A3F3D7405C60Q36011080-090F0143-BE41-4FF3-B0CC-D265077466F2Q36390338-BDEF0ED5-954F-4F2F-8F19-D01FB2A76EC1Q36597502-983A3D06-6929-4761-AD52-5781C540AAFCQ36782889-4472526C-5316-435F-886E-D5B8F0BC5772Q36880907-407E5866-E4FF-4829-9D87-3EBBB9A43C45Q36900701-C51572F7-E4EA-47BD-A965-E60C5BD2F93AQ37034014-63C0700E-CB32-4691-98B4-3236A8A3D0A0Q37143617-082853DD-0A86-4A8A-A2C2-63E300BD21C4Q37332632-4A5EC65C-8978-4982-9164-29C9E5AB6EDDQ37416747-7F752433-4DBC-42A4-B860-E323223943A6Q37463412-394D3DE2-859F-4D73-9F33-BF20AE2546B4Q37526981-40BD3B9F-3F35-40DF-B523-5B5B16E3A56CQ37712552-AB8D36DC-6961-4157-A654-AE8F20773069Q37800949-1A387222-B39B-4E2F-8ED6-55917398A937Q38030643-EDFBEFCB-4CB7-4979-ACFA-8A21B1F4032DQ38042744-CF82D7BF-BEE6-47E0-937A-AB85CE5D666FQ38082487-E751915B-0E00-4E05-8D6F-0DE0AEA03492
P2860
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparison of systemic availab ...... ated with phosphatidylcholine.
@ast
Comparison of systemic availab ...... ated with phosphatidylcholine.
@en
Comparison of systemic availab ...... ated with phosphatidylcholine.
@nl
type
label
Comparison of systemic availab ...... ated with phosphatidylcholine.
@ast
Comparison of systemic availab ...... ated with phosphatidylcholine.
@en
Comparison of systemic availab ...... ated with phosphatidylcholine.
@nl
prefLabel
Comparison of systemic availab ...... ated with phosphatidylcholine.
@ast
Comparison of systemic availab ...... ated with phosphatidylcholine.
@en
Comparison of systemic availab ...... ated with phosphatidylcholine.
@nl
P2093
P1476
Comparison of systemic availab ...... ated with phosphatidylcholine.
@en
P2093
Andreas J Gescher
Darren N Cooke
Paolo Morazzoni
Richard D Verschoyle
Timothy H Marczylo
William P Steward
P2888
P304
P356
10.1007/S00280-006-0355-X
P577
2006-10-19T00:00:00Z
P5875
P6179
1008654390